Six Phase 3 / Pivotal Trials with Array's MEK Inhibitors Expected to Initiate in 2013; One Trial Already Underway Boulder, Colo., (June 3, 2013) – Two Array BioPharma-invented MEK inhibitors, ...
Microarrays, including genome tiling microarrays, are exceptionally powerful tools for querying diverse genomic features, including mapping gene expression and structure, analyzing polymorphisms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results